ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 99 filers reported holding ACLARIS THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $26,000 | -38.1% | 1,784 | -25.0% | 0.00% | 0.0% |
| Q2 2021 | $42,000 | +500.0% | 2,378 | -61.4% | 0.00% | -50.0% |
| Q3 2019 | $7,000 | -46.2% | 6,157 | +7.1% | 0.00% | -50.0% |
| Q2 2019 | $13,000 | +85.7% | 5,749 | +1255.9% | 0.00% | 0.0% |
| Q1 2018 | $7,000 | +600.0% | 424 | +1827.3% | 0.00% | +300.0% |
| Q4 2017 | $1,000 | 0.0% | 22 | -54.2% | 0.00% | 0.0% |
| Q3 2017 | $1,000 | 0.0% | 48 | +29.7% | 0.00% | 0.0% |
| Q2 2017 | $1,000 | – | 37 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 1,258,243 | $8,618,965 | 13.75% |
| Foresite Capital Management IV, LLC | 2,808,034 | $19,235,033 | 10.68% |
| Bain Capital Life Sciences Investors, LLC | 3,400,000 | $23,290,000 | 2.60% |
| GREAT POINT PARTNERS LLC | 1,691,768 | $11,588,611 | 2.11% |
| Samsara BioCapital, LLC | 696,171 | $4,768,771 | 1.46% |
| Altium Capital Management LP | 403,000 | $2,760,550 | 1.44% |
| BVF INC/IL | 7,064,736 | $48,393,442 | 1.30% |
| Aisling Capital Management LP | 434,455 | $2,976,017 | 1.23% |
| GREAT POINT PARTNERS LLC | 700,000 | $4,795,000 | 0.87% |
| VR Adviser, LLC | 1,040,754 | $7,129,165 | 0.75% |